12 Health Care Stocks Moving In Tuesday's Pre-Market Session
GainersAxcella Health (NASDAQ:AXLA) shares rose 64.0% to $0.71 during Tuesday's pre-market session. The market value of their outstanding shares is at $51.8 million. Baudax Bio (NASDAQ:BXRX) stock inc
ElectroCore, Inc. (NASDAQ:ECOR) Sees Large Decline in Short Interest
electroCore, Inc. (NASDAQ:ECOR – Get Rating) was the target of a significant decrease in short interest in December. As of December 30th, there was short interest totalling 771,000 shares, a decreas
Why Calyxt Shares Are Trading Higher By Around 116%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Celyad Oncology SA (NASDAQ:CYAD) jumped 187% to $2.30 after gaining 21% on Friday. Celyad Oncology, last month, decided to discontinue the development of its remaining clinical program CYAD-21
ElectroCore Rises 10% on Guiding Record Revenue for Q4
ElectroCore Sees Q4 Sales ~$2.5M Vs. $2.17M Est., Sees FY22 Sales ~$8.5M Vs. $8.2M Est.
electroCore Sees Q4 sales ~$2.5M Vs. $2.17M Est., Sees FY22 Sales ~$8.5M Vs. $8.2M Est.
ElectroCore Sees 2022 Rev $8.5M >ECOR
ElectroCore Sees 1Q Rev $2.5M >ECOR
ElectroCore Sees 1Q Rev $2.5M >ECOR
ElectroCore, Inc. (NASDAQ:ECOR) to Post Q4 2022 Earnings of ($0.07) Per Share, Brookline Capital Management Forecasts
electroCore, Inc. (NASDAQ:ECOR – Get Rating) – Equities researchers at Brookline Capital Management issued their Q4 2022 EPS estimates for shares of electroCore in a note issued to investors on Th
ElectroCore (NASDAQ:ECOR) Now Covered by Brookline Capital Acquisition
Equities researchers at Brookline Capital Acquisition began coverage on shares of electroCore (NASDAQ:ECOR – Get Rating) in a report issued on Friday, Benzinga reports. The firm set a "buy" rating on
Benzinga's Top Ratings Upgrades, Downgrades For January 13, 2023
UpgradesFor OrganiGram Holdings Inc (NASDAQ:OGI), Stifel upgraded the previous rating of Hold to Buy. In the first quarter, OrganiGram Holdings showed an EPS of $0.01, compared to $0.00 from the year-
Loading...
No Stock Yet